Nikolin Branko, Imamović Belma, Medanhodzić-Vuk Saira, Sober Miroslav
Faculty of Pharmacy, University of Sarajevo.
Bosn J Basic Med Sci. 2004 May;4(2):5-9. doi: 10.17305/bjbms.2004.3405.
In testing the pre-sale procedure the marketing of drugs and their control in the last ten years, high performance liquid chromatography replaced numerous spectroscopic methods and gas chromatography in the quantitative and qualitative analysis. In the first period of HPLC application it was thought that it would become a complementary method of gas chromatography, however, today it has nearly completely replaced gas chromatography in pharmaceutical analysis. The application of the liquid mobile phase with the possibility of transformation of mobilized polarity during chromatography and all other modifications of mobile phase depending upon the characteristics of substance which are being tested, is a great advantage in the process of separation in comparison to other methods. The greater choice of stationary phase is the next factor which enables realization of good separation. The separation line is connected to specific and sensitive detector systems, spectrafluorimeter, diode detector, electrochemical detector as other hyphernated systems HPLC-MS and HPLC-NMR, are the basic elements on which is based such wide and effective application of the HPLC method. The purpose high performance liquid chromatography (HPLC) analysis of any drugs is to confirm the identity of a drug and provide quantitative results and also to monitor the progress of the therapy of a disease.1) Measuring presented on the Fig. 1. is chromatogram obtained for the plasma of depressed patients 12 h before oral administration of dexamethasone. It may also be used to further our understanding of the normal and disease process in the human body trough biomedical and therapeutically research during investigation before of the drugs registration. The analyses of drugs and metabolites in biological fluids, particularly plasma, serum or urine is one of the most demanding but one of the most common uses of high performance of liquid chromatography. Blood, plasma or serum contains numerous endogenous compounds often present in concentrations much greater than those of analyte. Analiyte concentrations are often low, and in the case of drugs, the endogenous compounds are sometimes structurally very similar to the drug to be measured. The binding of drugs to the plasma protein also may occur which decreases the amount of free compound that is measured. To undertake the analyses of drugs and metabolites in body fluids the analyst is facet with several problems. The first problem is due to the complex nature of the body fluid, the drugs must be isolated by an extraction technique, which ideally should provide a relatively clean extract, and the separation system must be capable of resolving the drugs of interest from co extractives. All mentioned when we are using high performance liquid chromatography require good selections of detectors, good stationary phase, eluents and adequate program during separation. UV/VIS detector is the most versatile detector used in high performance liquid chromatography it is not always ideal since it is lack of specificity means high resolution of the analyte that may be required. UV detection is preferred since it offers excellent linearity and rapid quantitative analyses can be performed against a single standard of the drug being determined. Diode array and rapid scanning detector are useful for peak identification and monitoring peak purity but they are somewhat less sensitive then single wavelength detectors. In liquid chromatography some components may have a poor UV chromophores if UV detection is being used or be completely retained on the liquid chromatography column. Fluorescence and electrochemical detector are not only considerably more sensitive towed appropriate analytes but also more selective than UV detectors for many compounds. If at all possible fluorescence detectors are sensitive, stable, selective and easy to operate. It is selectivity shows itself in the lack of frontal components observed in plasma extract whereas electrochemical detection is nearly always associated with a major frontal peak than tails considerably. To date, the most sensitive method has been the reductive electrochemical detection and giving the excellent results in the investigation on some classes of drugs. Several high performance liquid chromatography oxidative electrochemical methods have been developed for the analyses of drugs and metabolites in body fluids. Mass spectrometer as specific detector with all variation of ionisation and interface (thermo spray, moving belt etc. ) or liquid chromatography-tandem mass spectrometry2,3,4,5). NMR as selective and specific detector in high performance liquid chromatography today is also in used. The development of a non-aqueous eluent for ion-exchange separation on silica has provided an excellent system which, when used in conjugation with an electrochemical detector, permits the analyses of an extensive range of especially basic drugs and metabolites. New packing materials such as polymeric, base deactivated silica's, pyrolysed carbon and the internal surface packing should offer the improved stability and higher efficiencies for certain classes of the compounds such as basic drugs. Microbore columns should become more accepted since they offer not only improved sensitivity but also a lower solvent consumption and consequently the reduced needs to dispose of noxious solvents. Many analyses of basic drugs are still performed by the same method of the ion-exchange chromatography on unmodified silica columns with an eluent buffered to about pH 9. Neutral or weakly acidic drugs for instance barbiturates can be chromatographed on a reversed phase system whilst acidic drugs for example paracetamol, cannabis are separated either by ion suppression or ion-pair chromatography on a reversed-phase packing material. In micelar liquid chromatography micelar mobile phases in reversed-phase instead of conventional hydro organic mobile phase is used. In micelar liquid chromatography complex electrostatic hydrophobic and steric interactions exist between the solute and both stationary and mobile phases. These enable the effective separation of samples of different nature. The main advantages of the use of a micelar solution in reversed-phase liquid chromatography are the solvent and the lower cost and toxicity, the biodegradability of the solvent and the easy dissolution of analytical samples, that enables the determination of drugs in physiological fluids without the need for previous separation of the proteins present in the samples. Using tetrabutylammonium phosphate as a competing base in the investigation of sulphonamides and heptanes sulfonate as ion pairing reagent. Ion pairing reagent is term used to describe enhanced retention as the result of the addition to the mobile phase of a large ion opposite charge to the molecular ions to be separated. For molecular cations alkyl sulphates or sulfonates are generally utilised.
在测试过去十年药物的预售程序、营销及其管控时,高效液相色谱法在定量和定性分析中取代了众多光谱法和气相色谱法。在高效液相色谱法应用的初期,人们认为它会成为气相色谱法的补充方法,然而如今在药物分析中它几乎已完全取代了气相色谱法。与其他方法相比,液相流动相在色谱过程中可改变流动相极性以及根据被测物质特性对流动相进行的所有其他改性,这在分离过程中是一大优势。固定相的更多选择是实现良好分离的另一个因素。分离线连接到特定且灵敏的检测系统,光谱荧光计、二极管检测器、电化学检测器以及其他联用系统如高效液相色谱 - 质谱联用(HPLC - MS)和高效液相色谱 - 核磁共振联用(HPLC - NMR),是高效液相色谱法得以广泛有效应用所基于的基本要素。任何药物的高效液相色谱(HPLC)分析目的在于确认药物的身份、提供定量结果以及监测疾病治疗的进展。1)图1所示的测量是在口服地塞米松前12小时对抑郁症患者血浆进行检测得到的色谱图。它还可用于通过药物注册前调查期间的生物医学和治疗研究,进一步加深我们对人体正常和疾病过程的理解。生物流体,特别是血浆、血清或尿液中药物和代谢物的分析是高效液相色谱最具挑战性但也是最常见的用途之一。血液、血浆或血清含有众多内源性化合物,其浓度通常远高于分析物的浓度。分析物浓度往往很低,而且就药物而言,内源性化合物有时在结构上与待测药物非常相似。药物与血浆蛋白的结合也可能发生,这会减少所测游离化合物的量。要进行体液中药物和代谢物的分析,分析人员面临几个问题。第一个问题是由于体液性质复杂,必须通过萃取技术分离药物,理想情况下该技术应提供相对纯净的提取物,并且分离系统必须能够从共萃取物中分离出感兴趣的药物。当我们使用高效液相色谱时,上述所有情况都需要良好地选择检测器、固定相、洗脱剂以及分离过程中的适当程序。紫外/可见(UV/VIS)检测器是高效液相色谱中使用最广泛的检测器,但它并不总是理想的,因为它缺乏特异性,这意味着可能需要对分析物有高分辨率。紫外检测是首选,因为它具有出色的线性,并且可以针对所测药物的单一标准进行快速定量分析。二极管阵列和快速扫描检测器可用于峰识别和监测峰纯度,但它们的灵敏度比单波长检测器稍低。在液相色谱中,如果使用紫外检测,一些组分可能具有较差的紫外发色团,或者会完全保留在液相色谱柱上。荧光和电化学检测器不仅对适当的分析物灵敏度高得多,而且对许多化合物比紫外检测器更具选择性。如果可能的话,荧光检测器灵敏、稳定、选择性好且易于操作。其选择性表现为在血浆提取物中未观察到前沿组分,而电化学检测几乎总是与一个大的前沿峰相关,拖尾相当明显。迄今为止,最灵敏的方法是还原电化学检测,并且在某些类药物的研究中给出了优异的结果。已经开发了几种高效液相色谱氧化电化学方法用于体液中药物和代谢物的分析。质谱仪作为具有各种电离方式和接口(热喷雾、移动带等)的特定检测器,或者液相色谱 - 串联质谱联用2,3,4,5)。核磁共振作为高效液相色谱中的选择性和特异性检测器如今也在使用。用于硅胶上离子交换分离的非水洗脱剂的开发提供了一个出色的系统,当与电化学检测器结合使用时,允许分析广泛的特别是碱性药物和代谢物。新型填充材料,如聚合物、碱钝化硅胶、热解碳和内表面填充材料,对于某些类化合物如碱性药物应具有更高的稳定性和效率。微径柱应该会更受欢迎,因为它们不仅提高了灵敏度,而且溶剂消耗更低,因此减少了处理有害溶剂的需求。许多碱性药物的分析仍然通过在未改性硅胶柱上进行离子交换色谱的相同方法进行,洗脱剂缓冲至约pH 9。中性或弱酸性药物,例如巴比妥类药物,可以在反相系统上进行色谱分析,而酸性药物,例如对乙酰氨基酚、大麻,则通过反相填充材料上的离子抑制或离子对色谱法进行分离。在胶束液相色谱中,使用反相胶束流动相代替传统的水 - 有机流动相。在胶束液相色谱中,溶质与固定相和流动相之间存在复杂的静电、疏水和空间相互作用。这些相互作用使得能够有效分离不同性质的样品。在反相液相色谱中使用胶束溶液的主要优点是溶剂成本低且毒性小、溶剂可生物降解以及分析样品易于溶解,这使得无需事先分离样品中存在的蛋白质即可测定生理流体中的药物。在磺胺类药物的研究中使用磷酸四丁铵作为竞争碱,庚烷磺酸盐作为离子对试剂。离子对试剂是一个术语,用于描述由于向流动相中添加与待分离分子离子电荷相反的大离子而导致保留增强的情况。对于分子阳离子,通常使用烷基硫酸盐或磺酸盐。